Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol Meeting Abstract
| Authors: | Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M. |
| Abstract Title: | Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol |
| Meeting Title: | 2003 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics |
| Journal Title: | Clinical Cancer Research |
| Volume: | 9 |
| Issue: | 16 Pt. 2 |
| Meeting Dates: | 2003 Nov 17-21 |
| Meeting Location: | Boston, MA |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2003-12-01 |
| Start Page: | 6089s |
| Language: | English |
| ACCESSION: | WOS:000187467300084 |
| PROVIDER: | wos |
| PUBMED: | 14712828 |
| Notes: | Meeting Abstract: #A83 -- Poster Session A -- Source: Wos |
